- +852 4750 3485
- info@mycancerinfo.org
Many patients, survivors, and caregivers have heard the same warning repeated for years: “Hormones increase the risk of blood clots and cancer.”
This belief has shaped medical decisions, caused fear around hormone therapy, and led many women to avoid treatment that could improve quality of life.
But the reality is more nuanced—and far more empowering.
Hormones are not foreign substances. The human body produces them every day, from puberty through menopause and beyond. They regulate sleep, mood, metabolism, fertility, bone health, cardiovascular function, and brain health. If hormones themselves were inherently dangerous, human biology would not function.
The real concern lies elsewhere.
A critical distinction often gets lost in public discussion: natural (bio-identical) hormones are not the same as synthetic hormone medications.
Bio-identical hormones have the same molecular structure as hormones naturally produced by the human body. They interact with receptors in predictable, physiologic ways.
Synthetic hormone drugs, however, are chemically altered to mimic hormone effects. These compounds do not exist in nature. Because their structure differs, they may activate receptors differently, remain active longer, or trigger unintended biological pathways.
This difference explains why synthetic hormone drugs have been associated with higher risks of blood clots and certain cancers—while natural hormones, when used appropriately and monitored, do not show the same risk profile.
Understanding this distinction is the first step toward informed, personalized health decisions.
Much of the fear surrounding hormone therapy traces back to large population studies that reported increased cancer and cardiovascular risk. What is often overlooked is what type of hormones were studied.
These trials evaluated synthetic hormone formulations, not the hormones the body naturally produces. Applying those findings to all hormones—without distinction—created confusion and unnecessary fear.
This misinterpretation has had real consequences: patients avoiding care, unmanaged symptoms, and missed opportunities for prevention and long-term health support.
Scientific progress requires precision, not oversimplification.
One common misconception is that monthly bleeding automatically signals a healthy menstrual cycle.
In reality, bleeding alone does not equal ovulation.
A healthy menstrual cycle involves ovulation, followed by the natural release of progesterone. This hormone supports emotional stability, sleep quality, immune balance, cardiovascular health, and protection of reproductive tissues.
Medication-induced bleeding can occur without ovulation. In these cases, the body is responding to a hormonal signal—but not completing the full biological process of a healthy cycle. The appearance of regular bleeding can mask underlying hormonal imbalance.
Understanding this difference helps patients focus on meaningful markers of health rather than surface-level signs.
The effectiveness of cancer treatment varies among each patient.
Some individuals experience headaches, nausea, breast tenderness, or dizziness when hormone levels change—even when those hormones are bio-identical.
This does not mean the hormone is harmful.
Hormones act as messengers, not root causes. When the body is already under stress—due to inflammation, metabolic imbalance, nutrient deficiencies, or environmental exposures—normal hormonal fluctuations can amplify symptoms.
This is why two people with the same hormone levels may feel completely different.
The solution is not suppression, but investigation.
Chronic low-grade inflammation alters how cells respond to hormones. Inflammatory signals can disrupt hormone receptors, impair detoxification pathways, and increase sensitivity to normal hormonal changes.
Key measurable factors often involved include:
Addressing these factors helps the body respond to hormones as intended—without discomfort or risk amplification.
This approach shifts care from symptom suppression to long-term resilience.
Modern preventive health focuses less on guessing and more on measuring.
Instead of assuming risk, patients can work with clinicians to assess:
This data-driven approach allows for personalization, safer interventions, and early adjustments—long before disease develops.
Precision medicine recognizes that no two bodies are the same—and treatment should reflect that reality.
One powerful tool in this movement is liquid biopsy, a blood-based test that analyzes circulating biomarkers related to cellular health and disease activity.
For patients and caregivers, liquid biopsy can support:
Subtle molecular changes may appear in the blood before symptoms or imaging findings develop.
Individual biological risk can be assessed more accurately than population-based averages.
Changes in biomarkers over time help evaluate whether interventions are working.
Therapies can be adjusted based on real-time biological feedback, not trial-and-error.
Rather than reacting to disease, precision medicine empowers patients to anticipate, monitor, and adapt—placing control back in their hands.
Hormones are not enemies. They are essential messengers that reflect the body’s internal environment.
Risk arises not from hormones themselves, but from misapplied therapies, lack of monitoring, and failure to address underlying imbalances.
With modern testing, personalized care, and precision medicine tools, patients no longer have to choose between symptom relief and long-term safety.
Informed decisions replace fear.
Data replaces assumptions.
And health becomes a proactive partnership—not a guessing game.
North American Menopause Society. (2022). The 2022 hormone therapy position statement. https://www.menopause.org
National Cancer Institute. (2023). Hormones and cancer risk. https://www.cancer.gov
American College of Obstetricians and Gynecologists. (2021). Hormone therapy and cardiovascular risk. https://www.acog.org
Cleveland Clinic. (2023). Bioidentical hormones: What you need to know. https://health.clevelandclinic.org
National Institutes of Health. (2022). Inflammation and chronic disease. https://www.nih.gov
Nature Reviews Clinical Oncology. (2020). Liquid biopsy in precision oncology. https://www.nature.com
Precision medicine provides patients with clearer and more personalized treatment guidelines
Learn how precision medicine can help with your cancer treatment
The effectiveness of cancer treatment varies among each patient.
